Stay updated on Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page
- Check2 days agoChange DetectedIPD data-sharing section updated: Ipsen's data transparency link was added and data availability timing clarified. References to Vivli were removed.SummaryDifference0.3%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedPublications section updated to clarify that publications are automatically filled from PubMed and added Revision: v3.3.2. The prior PubMed-source phrasing and Revision: v3.2.0 reference were removed.SummaryDifference0.1%

- Check23 days agoChange DetectedNotice about potential outdated information due to a lapse in government funding has been removed from the page. Previously, the banner warned that information may not be up to date and that responses to inquiries could be delayed.SummaryDifference0.3%

- Check37 days agoChange DetectedDate-only updates were made to the Study Record Dates (e.g., 2025-10-29, 2025-10-27) with earlier dates removed. These are routine timestamp updates and do not modify trial design, eligibility, or results.SummaryDifference0.5%

- Check44 days agoChange DetectedAdded an estimated 'Last Update Posted' timestamp with new dates (2025-09 and 2025-10) and removed earlier entries (2025-07 and 2025-08).SummaryDifference0.2%

- Check66 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference2%

Stay in the know with updates to Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.